Lawrence Livermore National Laboratory (LLNL), in collaboration with the National Nuclear Security Administration (NNSA), Hewlett Packard Enterprise and AMD, have officially unveiled El Capitan as the world's most powerful supercomputer and first exascale system dedicated to national security.
Irvine, Calif., Nov. 18, 2024 — The severity of California’s wildfires has rapidly increased over the last several decades as a result of human-driven climate change, resulting in accelerated tree losses during more intense wildfires, an Environmental Research Letters study from University of California, Irvine and the University of Utah scientists reveals.
Donald Trump’s Cabinet selections, including Matt Gaetz, Tulsi Gabbard, Pete Hegseth, and Robert F. Kennedy Jr., are drawing criticism over qualifications and past controversies. ...
Researchers at Children’s Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy trial for Danon disease (DD), a rare, X-linked heart condition caused by a single gene mutation. The phase 1 trial was a collaboration between CHOP and the University of California, San Diego Medical Center, the University of Colorado, Anschutz Medical Center, Boston Children's Hospital and Rocket Pharmaceuticals. The data on the results of the RP-A501 Phase 1 trial, presented at a late breaking session today at the American Heart Association Scientific Sessions 2024 in Chicago, were also published in the New England Journal of Medicine.
طور باحثو مايو كلينك استراتيجية اختبار مبتكَرة للكشف عن ورم المتوسطة، قد تسهم في زيادة معدل الكشف عن الحمض النووي السرطاني في الدم. تركز هذه الطريقة على الأقسام المُعاد ترتيبها أو المُبدلة من الحمض النووي في خلايا ورم المتوسطة السرطانية، والتي تُعرف بإعادة ترتيب الكروموسومات.
New research published in JAMA Network Open from Keck Medicine of USC, which includes USC Norris Comprehensive Cancer Center, suggests that among all cancer survivors, male adolescents or young adults (AYA) have the highest rate of death by suicide.
Pesquisadores da Mayo Clinic desenvolveram uma estratégia de testes inovadora para a mesotelioma que pode ser capaz de aumentar a taxa de detecção do DNA do câncer no sangue.